Neuphoria Therapeutics Inc. (NEUP)

NASDAQ: NEUP · Real-Time Price · USD

3.700

-0.015 (-0.40%)

At close: Sep 18, 2026, 4:00 PM EDT

3.710

+0.010 (0.27%)

After-hours: Sep 18, 2026, 7:30 PM EDT

Neuphoria Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Cash & Equivalents	19.87	14.21	12.61	12.1	23.13
Cash & Short-Term Investments	19.87	14.21	12.61	12.1	23.13
Cash Growth	39.79%	12.71%	4.17%	-47.66%	8.23%
Other Receivables	0.81	0.01	0.13	0.43	4.67
Receivables	0.81	0.01	0.13	0.43	4.67
Prepaid Expenses	0.39	0.74	0.46	0.8	1.01
Restricted Cash	-	0.08	-	-	-
Total Current Assets	21.07	15.04	13.19	13.33	28.81
Property, Plant & Equipment	-	0.11	0.22	0.33	0.46
Goodwill	3.5	8.64	8.69	8.69	8.87
Other Intangible Assets	4.14	4.8	5.47	6.13	6.78
Other Long-Term Assets	-	-	0.08	0.08	0.08
Total Assets	28.71	28.59	27.65	28.56	45

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Accounts Payable	0.39	1.15	2.24	1.44	1.07
Accrued Expenses	0.28	2.88	1.39	1.19	1.13
Short-Term Debt	0.03	0.03	0.03	-	-
Current Portion of Leases	-	0.12	0.12	0.11	0.11
Other Current Liabilities	0.05	0.04	0.04	-	-
Total Current Liabilities	0.76	4.22	3.83	2.74	2.31
Long-Term Leases	-	-	0.12	0.24	0.37
Pension & Post-Retirement Benefits	-	-	-	-	0.01
Long-Term Deferred Tax Liabilities	0.36	0.5	0.96	1.1	1.24
Other Long-Term Liabilities	3	4.87	5.25	2.47	1.86
Total Liabilities	4.11	9.59	10.16	6.55	5.79

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Common Stock	0	0	0	-	149.99
Additional Paid-In Capital	218.46	200.19	198.48	187.55	-
Retained Earnings	-191.8	-178.35	-177.98	-162.48	-119.41
Comprehensive Income & Other	-2.06	-2.85	-3.01	-3.06	8.63
Shareholders' Equity	24.6	19	17.49	22.01	39.21
Total Liabilities & Equity	28.71	28.59	27.65	28.56	45

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Total Debt	0.03	0.15	0.27	0.35	0.48
Net Cash (Debt)	19.83	14.06	12.34	11.75	22.65
Net Cash Growth	41.03%	13.99%	4.99%	-48.12%	9.32%
Net Cash Per Share	4.51	8.66	14.82	0.01	0.02
Filing Date Shares Outstanding	5.41	2.36	3,118	1,469	1,353
Total Common Shares Outstanding	5.41	1.98	2,385	1,469	1,353
Working Capital	20.31	10.82	9.36	10.59	26.49
Book Value Per Share	4.55	9.60	0.01	0.01	0.03
Tangible Book Value	16.96	5.56	3.33	7.19	23.57
Tangible Book Value Per Share	3.13	2.81	0.00	0.00	0.02

SEC Filings: 10-K · 10-Q